| Literature DB >> 24790827 |
Olga S Petrakova1, Vasiliy V Terskikh2, Elena S Chernioglo2, Vasiliy V Ashapkin3, Evgeny Y Bragin4, Victoria Y Shtratnikova4, Inessa G Gvazava5, Yuriy V Sukhanov2, Andrey V Vasiliev2.
Abstract
Mouse submandibular salivary gland cells and liver progenitor cells from long-term in vitro cultures with a high proliferation potential were side-by-side compared by methods of immunocytochemistry, quantitative real-time PCR, flow cytometry, and transcriptome analysis. The two cell types were found to be similar in expressing cell markers such as EpCAM, CD29, c-Kit, Sca-1, and c-Met. In addition, both cell types expressed cytokeratins 8, 18, and 19, alpha-fetoprotein, and (weakly) albumin. Unlike the liver cells, however, the salivary gland cells in culture showed high-level expression of cytokeratin 14 and CD49f, which was indicative of their origin from salivary gland ducts. Quantitative real-time PCR and deep-sequencing transcriptome analysis revealed similarities in the expression pattern of transcription factors between the two cell types. In this respect, however, the cultured salivary gland cells proved to be closer to exocrine cells of the pancreas than to the liver progenitor cells. Thus, ductal cells of postnatal submandibular salivary glands in culture show phenotypic convergence with progenitor cells of endodermal origin, suggesting that these glands may serve as a potential cell source for cellular therapy of hepatic and pancreatic disorders. The results of this study provide a deeper insight into the molecular features of salivary gland cells and may help optimize procedures for stimulating their differentiation in a specified direction.Entities:
Keywords: Gene expression; Liver cells; Submandibular salivary gland cells; Transcriptome
Year: 2014 PMID: 24790827 PMCID: PMC4000360 DOI: 10.1186/2193-1801-3-183
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Figure 1The morphology of mouse salivary gland and liver progenitor cells (phase contrast microscopy; scale bars = 100 μm): (A) SGC monolayer, primary culture; (B) LPC monolayer, primary culture; (C) SGC monolayer, passage 1; (D) LPC monolayer, passage 1. Cell heterogeneity is manifested in passage 1 monolayers (C, D), where groups of small actively proliferating cells (thin arrows) and large multinuclear cells (thick arrows) can be seen.
Antibodies used in the study (asterisks indicate antibodies used for flow cytometry)
| Antibody | Manufacturer, catalog number | Species | Dilution |
|---|---|---|---|
|
| |||
| AFP* | R&D, # MAB1368 | mouse anti-human/mouse IgG1 | 1:200 |
| ALB* | R&D, # MAB1455 | mouse anti-human/mouse IgG2a | 1:200 |
| CD29* | Millipore, # FCMAB269F | rat anti-mouse IgG2aκ | 2 μl per 106 cells |
| CD49f* | Millipore, # MAB1378 | rat anti-human/mouse IgG2a | 1:10 |
| CD45* | Millipore, # FCMAB126F | mouse anti-human/mouse IgG2bκ | 10 μl per 106 cells |
| CD90* | Millipore, # CBL1500F | mouse anti-rat/mouse IgG1 | 10 μl per 106 cells |
| CD133* | Millipore, # MAB4310X | rat anti- mouse IgG1κ | 1:200 |
| CK8 | AbCam, # ab59400 | rabbit anti-human/rat/mouse IgG | 1:500 |
| CK14 | Chemicon, # CBL197 | mouse anti-human IgG3 | 1:100 |
| CK18 | Millipore, # MAB3234 | mouse anti-human/mouse IgG1 | 1:100 |
| CK19* | AbCam, # ab15463-1 | rabbit anti-human/ mouse IgG | 1:100 |
| CYP P450 1A1 | Millipore, # AB1258 | rabbit anti-human | 1:100 |
| c-Kit* | Millipore, # CBL1360 | rat anti- mouse IgG2bκ | 1 μl per 106 cells |
| c-Met* | Millipore, # MAB3729 | mouse anti-human/mouse IgG1 | 1:500 |
| EpCAM* | Abcam, # ab32392 | rabbit anti-human/rat/mouse IgG | 1:500 |
| Hnf-3β | Millipore, # 07-633 | rabbit anti-human/rat/mouse IgG | 1:200 |
| Hnf-4α | Santa Cruz, # SC-8987 | rabbit anti-human/rat/mouse IgG | 1:200 |
| INS | R&D, # MAB1417 | rat anti-human/bovine/mouse IgG2A | 1:200 |
| Ki67 | Millipore, # MAB4190 | mouse anti-human IgG1 | 1:200 |
| NGF | Millipore, # 04-1111 | rabbit anti-human/rat/mouse IgG | 1:200 |
| Sca-1* | Millipore, # FCMAB224F | rat anti-mouse IgG2aκ | 2 μl per 106 cells |
|
| |||
| Alexa Fluor® 488* | Invitrogen, # A-21206 | donkey anti-rabbit IgG (H + L) | 1:1000 |
| Alexa Fluor® 546 | Invitrogen, # A-11035 | goat anti-rabbit IgG (H + L) | 1:1000 |
| Alexa Fluor® 488* | Invitrogen, # A-11029 | goat anti-mouse IgG (H + L) | 1:1000 |
| Alexa Fluor® 488* | Invitrogen, # A-11006 | goat anti-rat IgG (H + L) | 1:1000 |
Figure 2Immunocytochemical analysis of first-passage salivary gland and liver progenitor cells, fluorescent microscopy. Cell nuclei were stained with DAPI (blue), the antigens were detected with Alexa Fluor 488-conjugated antibodies (green), scale bars = 100 μm.
Figure 3Immunocytochemical analysis of first-passage salivary gland and liver progenitor cells, fluorescent microscopy. Cell nuclei were stained with DAPI (blue), the antigens were detected using antibodies conjugated with Alexa Fluor 488 (green) and Alexa Fluor 546 (red), scale bars = 100 μm.
Figure 4Quantitative RT-PCR analysis of first-passage salivary gland and liver progenitor cells for mRNAs of different cell markers (relative to GAPDH mRNA expression level taken as 1). Blue and red bars refer to SGC and LPC, respectively. (A) Liver-enriched transcription factors; (B) liver-specific cell differentiation markers; (C) pancreas-enriched transcription factors.
Expression analysis of genes for surface antigens and cell differentiation markers by deep sequencing in first-passage SGC and LPC cultures (data are normalized for the total number of reads)
| Gene | Read number per mRNA (x10−6) | SGC/LPC ratio of gene read numbers | |
|---|---|---|---|
| SGC | LPC | ||
|
| 499 | 2.336 | 214 |
|
| 4.613 | 9.466 | 0.5 |
|
| 0.686 | 0.121 | 5.7 |
|
| 174 | 90.168 | 2 |
|
| 79.954 | 5.218 | 15 |
|
| 136 | 0.485 | 280 |
|
| 0.405 | 0.212 | 2 |
|
| 54.861 | 33.525 | 1.6 |
|
| 0.218 | 0 | - |
|
| 0.686 | 1.123 | 0.6 |
|
| 742 | 22.087 | 34 |
|
| 30.579 | 38.318 | 0.8 |
|
| 1.403 | 0.728 | 1.9 |
|
| 1.091 | 2.245 | 0.5 |
|
| 0.03 | 0.212 | 0.14 |
|
| 99.436 | 19.296 | 5 |
|
| 2.213 | 0.698 | 3 |
|
| 0.187 | 0.212 | 1 |
|
| 0.094 | 0.061 | 1.5 |
|
| 0.03 | 0.212 | 0.14 |
|
| 0.125 | 0.121 | 1 |
|
| 1079.738 | 14.532 | 74 |
|
| 0.218 | 0 | - |
|
| 0.094 | 0.061 | 1.5 |
Expression analysis of genes for transcription factors by deep sequencing in first-passage SGC and LPC cultures (data are normalized for the total number of reads)
| Gene | Read number per mRNA (x10−6) | SGC/LPC ratio of gene read numbers | |
|---|---|---|---|
| SGC | LPC | ||
|
| 0.125 | 15.989 | 0.008 |
|
| 0.125 | 17.597 | 0.007 |
|
| 0.062 | 1.244 | 0.05 |
|
| 0.031 | 9.132 | 0.003 |
|
| 41.832 | 2.457 | 17 |
|
| 0.405 | 4.581 | 0.1 |
|
| 0 | 0.061 | 0 |
|
| 0.03 | 13.106 | 0.0002 |
|
| 0 | 0 | - |
|
| 0.187 | 0.303 | 0.6 |
|
| 0.53 | 5.097 | 0.1 |
|
| 172.626 | 11.165 | 15.5 |
|
| 0 | 1.001 | 0 |
|
| 9.351 | 31.886 | 0.3 |
|
| 5.891 | 1.517 | 4 |
|
| 0.468 | 1.365 | 0.3 |
|
| 0.249 | 16.565 | 0.02 |
|
| 82.23 | 67.656 | 1.2 |
|
| 135.283 | 93.566 | 1.4 |
Flow cytometry analysis of first-passage SGC and LPC cultures
| Cell marker | SGC | LPC |
|---|---|---|
|
| 73.3 ± 4.9 | 71.9 ± 2.5 |
|
| 82.6 ± 2.7 | 89.8 ± 4.8 |
|
| 67.4 ± 6.3 | 69.9 ± 0.7 |
|
| 93.8 ± 2.1 | 70.2 ± 4.8 |
|
| 93.3 ± 1.0 | 52.2 ± 3.2 |
|
| 87.8 ± 3.4 | 1.7 ± 0.2 |
|
| 0.1 ± 0.1 | 3.0 ± 0.8 |
|
| 3.7 ± 0.7 | 21.1 ± 2.3 |
|
| 10.0 ± 1.6 | 31.1 ± 0.7 |
|
| 2.1 ± 0.2 | 1.9 ± 0.5 |
|
| 2.2 ± 0.1 | 10.9 ± 1.3 |
|
| 69.1 ± 2.4 | 12.3 ± 0.4 |
Background fluorescence level was 0.2 ± 0.1%.
Figure 5Immunocytochemical analysis of EpCAM expression features in first-passage SGC culture. Cell nuclei were stained with DAPI (blue), EpCAM was stained with Alexa Fluor 488-conjugated antibodies (green), and alpha-fetoprotein was stained with Alexa Fluor 546-conjugated antibodies (red); scale bars = 100 μm: (A) membrane localization of EpCAM (paraformaldehyde fixation without Triton X-100); (B) cytoplasmic localization of EpCAM (fixation with 70% ethanol); (C) alpha-fetoprotein; (D) EpCAM; (E) coexpression of alpha-fetoprotein and EpCAM.
Primers used in qRT-PCR
| Primer | Gene | Nucleotide sequence | Amplicon size | Melting point |
|---|---|---|---|---|
| bp | °C | |||
|
| ||||
| mGAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 5′- AGG TCG GTG TGA ACG GAT TTG -3′ | 95 | 62.6 |
| 5′- GGG GTC GTT GAT GGC AAC A -3′ | 62.6 | |||
|
| ||||
| m1AAT | Alpha-1-antitrypsin | 5′- CTC GTC CGC TCA CTA AAC AAG -3′ | 248 | 60.7 |
| 5′- GCT GTC TGA GAG TCA AGG TCT T -3′ | 61.3 | |||
| mAFP | Alpha-fetoprotein | 5′- CCA TCA CCT TTA CCC AGT TTG T -3′ | 101 | 60.2 |
| 5′- CCC ATC GCC AGA GTT TTT CTT -3′ | 60.6 | |||
| mALB | Albumin | 5′- TGC TTT TTC CAG GGG TGT GTT -3′ | 167 | 62.4 |
| 5′- TTA CTT CCT GCA CTA ATT TGG CA -3′ | 60.2 | |||
| mCYP7A1 | Cytochrome P450, family 7, subfamily a, polypeptide 1 | 5′- AAC GGG TTG ATT CCA TAC CTG G -3′ | 126 | 62.0 |
| 5′- GTG GAC ATA TTT CCC CAT CAG TT -3′ | 60.0 | |||
| mG6P | Glucose-6-phosphatase | 5′- CGA CTC GCT ATC TCC AAG TGA -3′ | 208 | 61.0 |
| 5′- GGG CGT TGT CCA AAC AGA AT -3′ | 60.9 | |||
| mPEPCK | Phosphoenolpyruvate carboxykinase 1 | 5′- TGA CAG ACT CGC CCT ATG TG -3′ | 153 | 61.0 |
| 5′- CCC AGT TGT TGA CCA AAG GC -3′ | 61.4 | |||
| mTAT | Tyrosine aminotransferase | 5′- AGC CGA ATC CGA ACA AAA CC -3′ | 146 | 60.9 |
| 5′- GCC GAT AGA TGG GGC ATA GC -3′ | 61.3 | |||
| mTDO | Tryptophan 2,3-dioxygenase | 5′- AAT CCA TGA CGA GCA CCT ATT CA -3′ | 140 | 61.4 |
| 5′- TCA CCT TGA GCA TGT TCC TCT -3′ | 60.8 | |||
|
| ||||
| mHnf3α | Forkhead box A1 (Foxa1) | 5′- GGA GTT GAA GTC TCC AGC GTC -3′ | 157 | 62.4 |
| 5′- GGG GTG ATT AAA GGA GTA GTG GG -3′ | 61.7 | |||
| mHnf3β | Forkhead box A2 (Foxa2) | 5′- TCC GAC TGG AGC AGC TAC TAC -3′ | 176 | 62.8 |
| 5′- GCG CCC ACA TAG GAT GAC A -3′ | ||||
| mHhex | Hematopoietically expressed homeobox | 5′- CGA GAC TCA GAA ATA CCT CTC CC -3′ | 162 | 61.2 |
| 5′- CTG TCC AAC GCA TCC TTT TTG -3′ | 60.0 | |||
| mTbx3 | T-box 3 (Tbx3), transcript variant 2 | 5′- TGG AAC CCG AAG AAG ACG TAG -3′ | 84 | 61.2 |
| 5′- TAC CCC GCT TGT GAA ACT GG -3′ | 62.1 | |||
|
| ||||
| mHes1 | Hairy and enhancer of split 1 | 5′- TCA ACA CGA CAC CGG ACA AAC -3′ | 155 | 63.0 |
| 5′- ATG CCG GGA GCT ATC TTT CTT -3′ | 61.0 | |||
| mNgn3 | Neurogenin 3 | 5′- CCA AGA GCG AGT TGG CAC T -3′ | 236 | 62.3 |
| 5′- CGG GCC ATA GAA GCT GTG G -3′ | 62.5 | |||
| mPax4 | Paired box gene 4 | 5′- GCA GTG TGA ATC AGC TAG GGG -3′ | 103 | 62.5 |
| 5′- CAG GGT CGC ATC CCT CTT ATT -3′ | 61.3 | |||
| mPax6 | Paired box gene 6 | 5′- AAC AGT CAC AGC GGA GTG AAT -3′ | 196 | 61.7 |
| 5′- ACA CAA CCG TTG GAT ACG TTT T -3′ | 60.7 | |||
| mPdx1 | Pancreatic and duodenal homeobox 1 | 5′- CCC CAG TTT ACA AGC TCG CT -3′ | 117 | 62.2 |
| 5′- CTC GGT TCC ATT CGG GAA AGG -3′ | 62.7 | |||
| mPtf1a | Pancreas specific transcription factor, 1a | 5′- GCT ACA CGA ATA CTG CTA CCG -3′ | 134 | 60.3 |
| 5′- CGC AGC AAT AGC TGA CGT TG -3′ | 62.0 | |||